All Updates

All Updates

icon
Filter
Funding
Genesis Therapeutics raises USD 200 million in Series B funding
AI Drug Discovery
Aug 21, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Aug 21, 2023

Genesis Therapeutics raises USD 200 million in Series B funding

Funding

  • California-based AI drug discovery startup Genesis Therapeutics has raised USD 200 million in a Series B funding round co-led by a US-based life sciences-focused investor (name undisclosed) and Andreessen Horowitz Bio + Health, with participation from other existing and new investors. This brings the total funds raised by the company to over USD 280 million.

  • The funds will be used to further develop the company’s AI-powered Genesis Exploration of Molecular Spaces (GEMS) platform, advance its pipeline of therapeutic candidates into clinical development, and further expand its pipeline with new programs. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.